Pacific Bio (PACB) Reports Q4 Revenues of $24.9 Million

Pacific Bio (NASDAQ: PACB) reported Q4 revenue of $24.9 million, versus $24.4 million reported last year.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c